Drugs / Amyl Nitrite
Amyl Nitrite
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT02428959 | Jun 2014 → Dec 2018 | achalasia | Johns Hopkins University | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT04905173 Background | Nov 2021 → May 2022 | hypertrophic cardiomyopathy | Mayo Clinic | Withdrawn | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amyl Nitrite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02428959 ↗ |
| Known as | Amyl nitrite (mixed isomers) | ChEMBL registry synonym — accepted as the source's own label CHEMBL6195748 ↗ |
| Known as | Amyl nitrosum | ChEMBL registry synonym — accepted as the source's own label CHEMBL6195748 ↗ |
| Known as | Nitramyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL6195748 ↗ |
| Modality | Small molecule | “Amyl nitrite is the chemical compound” NCT02428959 ↗ |
| Route | Inhaled | “The method of administration is via inhalation” NCT02428959 ↗ |